STEVE EARL MUSICK M.D. NPI 1831176775

NPI Details

Steve Earl Musick, M.D. is a dermatology in Swansea, IL with 36 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. Steve Earl Musick, M.D. NPI is 1831176775. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Graduation Year:1989

The provider's business location address is:

4948 BENCHMARK CENTRE DR
SWANSEA, IL
ZIP 62226-027
Phone: (618) 628-2588
Fax: (618) 628-1363

The NPI 1831176775 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS:J7345)
• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Ultrasonic guidance for placement of radiation therapy fields (HCPCS:G6001)
• Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS:77280)
• Superficial and/or low voltage radiation treatment delivery (HCPCS:77401)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Radiation treatment management, 5 treatment sessions (HCPCS:77427)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Continuing radiation therapy consultation per week (HCPCS:77336)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Calculation of radiation therapy dose (HCPCS:77300)
• Application of light by qualified health care professional to destroy precancer skin growth (HCPCS:96573)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Design and construction of complex radiation treatment device (HCPCS:77334)
• Simple radiation therapy planning (HCPCS:77261)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Biopsy of ear (HCPCS:69100)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:17280)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm (HCPCS:12042)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Design and construction of simple radiation treatment device (HCPCS:77332)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:17270)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11622)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 12/30/2005 and was last updated on 7/22/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.